Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sage Therapeutic Com (NQ: SAGE )

74.34 USD -2.27 (-2.96%)
Streaming Delayed Price Updated: 11:33 AM EDT, Apr 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Sage Therapeutic Com

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today reported topline results from the Phase 2 KINETIC Study evaluating SAGE-324 in the treatment of people with essential tremor... 
From Business Wire News Releases
Sage Therapeutics to Present at the Stifel 3rd Annual CNS Day
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics Announces Continued Positive Zuranolone Data for Both 30 mg and 50 mg Doses in Open-Label SHORELINE Study in Patients with MDD
Sage Therapeutics, Inc. (Nasdaq: SAGE) today reported complete 12-month data from the 30 mg cohort and interim data from the 50 mg cohort of the ongoing Phase 3 open-label SHORELINE Study. This... 
From Business Wire News Releases
Sage Therapeutics Announces Departure of Chief Operating Officer
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating brain disorders, today... 
From Business Wire News Releases
An App That Makes Financial Sense for Older LGBTQ Adults
Tags NYSE:WFC Philanthropy & Cause Initiatives Diversity & Inclusion
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the... 
From Business Wire News Releases
Sage Therapeutics to Present at Upcoming Investor Conferences
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics Announces the Appointment of Barry Greene as CEO
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating brain disorders, today... 
From Business Wire News Releases
Sage Therapeutics to Present at BMO 2020 Growth & ESG Conference
Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
The Biotech Breakthrough Transforming Mental Health
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
The Biotech Breakthrough Transforming Mental Health
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary 
From PR Newswire
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
From GlobeNewswire News Releases
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone... 
From Business Wire News Releases
Sage Therapeutics, Inc. (NASDAQ:SAGE) Investor Notice: Lawsuit Filed over Pay for Non-Employee Directors
San Diego, CA -- (SBWIRE) -- 11/13/2020 -- An investor of Sage Therapeutics, Inc. (NASDAQ:SAGE) shares filed a lawsuit in connection with the pay for non-employee directors of Sage Therapeutics, Inc. 
From SBWire - Latest Press Releases
Savvy Companies Making Moves in Drug-Development Space
From InvestorBrandNetwork
Savvy Companies Making Moves in Drug-Development Space
NetworkNewsWire Editorial Coverage 
From PR Newswire
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the... 
From Business Wire News Releases
Sage Therapeutics to Present at Upcoming November Investor Conferences
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics Announces Chief Executive Jeff Jonas to Undergo Scheduled Medical Procedure
Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the... 
From Business Wire News Releases
Sage Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating brain disorders, today... 
From Business Wire News Releases
Sage Therapeutics Appoints Barry Greene to Board of Directors
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Should you invest in NortonLifeLock, Nike, JinkoSolar, SAGE Therapeutics, or Microsoft?
InvestorsObserver issues critical PriceWatch Alerts for NLOK, NKE, JKS, SAGE, and MSFT. 
From PR Newswire
Sage Therapeutics’ FutureCast to Provide Update on Pipeline Progression and Additional Insights into Potential of Brain Health Franchises
Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the... 
From Business Wire News Releases
Sage Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference
Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shareholder Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 08/31/2020 -- An investigation was announced concerning potential securities laws violations by Sage Therapeutics, Inc. in connection with certain financial statements. 
From SBWire - Latest Press Releases
Sage Therapeutics to Host Sage FutureCast Webcast
Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.